NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
October 13 2023 - 9:30AM
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)
("NeuroOne" or the "Company"), a medical technology company focused
on improving surgical care options and outcomes for patients
suffering from neurological disorders, today announced that CFO Ron
McClurg will present at the ThinkEquity Conference in New York on
Thursday, October 19, 2023.
Conference details:
Presentation Date: |
Thursday, October 19, 2023 |
Presentation Time*: |
9:00 am ET |
Location: |
Mandarin Oriental Hotel, New York City |
Registration: |
Available on the conference website. |
1x1 meetings: |
Requests available upon registration. |
|
|
*The presentation time may be subject to
change. Attendees may refer to the program agenda for more
information.
About NeuroOne
NeuroOne Medical Technologies Corporation is a
developmental stage company committed to providing minimally
invasive and hi-definition solutions for EEG recording, brain
stimulation and ablation solutions for patients suffering from
epilepsy, Parkinson's disease, dystonia, essential tremors, chronic
pain due to failed back surgeries and other related neurological
disorders that may improve patient outcomes and reduce procedural
costs. The Company may also pursue applications for other areas
such as depression, mood disorders, pain, incontinence, high blood
pressure, and artificial intelligence. For more information, visit
nmtc1.com.
Caution: Federal law restricts this device to
sale by or on the order of a physician.
Contact:800-631-4030ir@nmtc1.com
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
NeuroOne Medical Technol... (NASDAQ:NMTC)
Historical Stock Chart
From Jul 2023 to Jul 2024